Meeting Companies Where They Are: A Validation Perspective

At Brayearst Validation Consulting, we believe that good science leads to great outcomes when we meet companies where they are.

In a recent interview with InfoPathways, I shared how our approach to validation is designed to support life science companies across a broad spectrum of readiness—from early startups to scaling manufacturers.

Some organizations come to us after trying to validate on their own, only to run into trouble with internal reviews or FDA expectations. Others are just gearing up to manufacture for the first time, whether it’s for clinical trials or commercial distribution. No matter the starting point, the goal is the same: safe, effective, and reliable products backed by solid validation practices.

That’s why we offer services like Validation Spot Checks—objective reviews of current practices—to catch potential gaps before an audit ever happens. For teams moving from the lab bench to a CDMO or their own suites, we help lay the foundation for scale with robust validation across processes, cleaning, methods, and software.

Even earlier in the journey, before the first product is made, training plays a critical role. It equips future innovators with the foresight to consider validation requirements long before manufacturing begins.

Our job isn’t to force companies into a one-size-fits-all mold. It’s to empower them, step by step, to build confidence in their processes and compliance. Wherever you are, we’ll meet you there—and help you move forward with clarity.

Watch the interview snippet

Watch the Full Interview

Previous
Previous

What Is Validation? Making the Complex Clear for Life Sciences Teams

Next
Next

The Biggest Risk for Small Companies – Why Validation Matters